FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+8.73%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$26B
AUM Growth
+$926M
(+3.7%)
Cap. Flow
-$723M
Cap. Flow
% of AUM
-2.78%
Top 10 Holdings %
Top 10 Hldgs %
34.84%
Holding
584
New
79
Increased
150
Reduced
231
Closed
76
Top Buys
| 1 |
Qualcomm
QCOM
|
$186M |
| 2 |
Meta Platforms (Facebook)
META
|
$185M |
| 3 |
Walt Disney
DIS
|
$155M |
| 4 |
Nike
NKE
|
$146M |
| 5 |
Apple
AAPL
|
$143M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$345M |
| 2 |
Amazon
AMZN
|
$174M |
| 3 |
Royal Caribbean
RCL
|
$161M |
| 4 |
RHT
Red Hat Inc
RHT
|
$125M |
| 5 |
Visa
V
|
$105M |
Sector Composition
| 1 | Technology | 29.14% |
| 2 | Healthcare | 22.1% |
| 3 | Consumer Discretionary | 13.75% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Encompass Health
EHC
$12.6B
| – | – |
-250
| Closed | -$12K |
|
527
Emerson Electric
EMR
$75.6B
| – | – |
-205
| Closed | -$14K |
|
528
Evolus
EOLS
$495M
| – | – |
-8,000
| Closed | -$181K |
|
529
FMC
FMC
$4.71B
| – | – |
-14,472
| Closed | -$1.11M |
|
530
Amicus Therapeutics
FOLD
$2.5B
| – | – |
-70,000
| Closed | -$952K |
|
531
Fortinet
FTNT
$59.4B
| – | – |
-835
| Closed | -$14K |
|
532
GoDaddy
GDDY
$20.2B
| – | – |
-373
| Closed | -$28K |
|
533
Herbalife
HLF
$1.04B
| – | – |
-230
| Closed | -$12K |
|
534
Intel
INTC
$107B
| – | – |
-42,288
| Closed | -$2.27M |
|
535
CarMax
KMX
$9.27B
| – | – |
-207
| Closed | -$14K |
|
536
Kezar Life Sciences
KZR
$28M
| – | – |
-1,800
| Closed | -$319K |
|
537
Lyft
LYFT
$7.06B
| – | – |
-698
| Closed | -$55K |
|
538
Mastercard
MA
$540B
| – | – |
-205
| Closed | -$48K |
|
539
Medpace
MEDP
$13.7B
| – | – |
-23,265
| Closed | -$1.37M |
|
540
3M
MMM
$83.3B
| – | – |
-2,753
| Closed | -$478K |
|
541
Moderna
MRNA
$9.71B
| – | – |
-21,000
| Closed | -$427K |
|
542
Nutanix
NTNX
$18.8B
| – | – |
-252,265
| Closed | -$9.52M |
|
543
Novo Nordisk
NVO
$248B
| – | – |
-28,000
| Closed | -$732K |
|
544
Omnicell
OMCL
$1.52B
| – | – |
-19,000
| Closed | -$1.54M |
|
545
Ovintiv
OVV
$10.8B
| – | – |
-7,263
| Closed | -$263K |
|
546
Pacira BioSciences
PCRX
$1.21B
| – | – |
-26,000
| Closed | -$990K |
|
547
Pinduoduo
PDD
$177B
| – | – |
-1,706,694
| Closed | -$42.3M |
|
548
Protolabs
PRLB
$1.2B
| – | – |
-14
| Closed | -$1K |
|
549
Qorvo
QRVO
$8.63B
| – | – |
-11,154
| Closed | -$800K |
|
550
Regions Financial
RF
$24.6B
| – | – |
-26,568
| Closed | -$376K |
|